Skip to main content
Fig. 3 | Gynecologic Oncology Research and Practice

Fig. 3

From: Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience

Fig. 3

Kaplan-Meier plots of survival in patients with metastatic vaginal or vulvar cancer and a body mass index (BMI) of ≥30 (n = 6; median, 13.2 months; 95 % CI, 0–27.5 months). These patients survived significantly longer than did those whose BMI was <30 (n = 21; 4.4 months; 3.1–5.7 months) (p = 0.04)

Back to article page

Gynecologic Oncology Research and Practice

ISSN: 2053-6844

Contact us